B-cell lymphoma cell line
Export
B cell lymphoma line, EBV transformed
Cell Type:
B cell
Tissue Origin:
Species:
human
Research Area:
Cancer Research/Cell Biology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
C
X-001
3e6
65%
62%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.
Categories:
Transfection
Authors:
Amabile A, Migliara A, Capasso P, Biffi M, Cittaro D, Naldini L, Lombardo A.
In:
Cell (2016) 167(1): 219-232
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells
Categories:
Transfection
Authors:
Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, Sharkis S, Ye Z, Jang YY
In:
Blood (2011) 118(7): 1801-5
Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules.
Categories:
Classical Media and Reagents, Serum-free and Speciality Media
Authors:
Shaikh SR, Edidin M
In:
J Lipid Res (2007) 48(1): 127-38